BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10216700)

  • 1. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
    Patole S; Lee J; Whitehall J
    Indian Pediatr; 1998 Dec; 35(12):1221-4. PubMed ID: 10216700
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
    Patole S; Lee J; Whitehall J
    Indian Pediatr; 1999 Mar; 36(3):307-10. PubMed ID: 10713845
    [No Abstract]   [Full Text] [Related]  

  • 3. Present and future of European neonatology: focus on patent ductus arteriosus.
    Fanos V; Guimarâes H
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():1-2. PubMed ID: 19925356
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of indomethacin infused over 30 minutes on cerebral fractional tissue oxygen extraction in preterm newborns with a patent ductus arteriosus.
    Keating P; Verhagen E; van Hoften J; ter Horst H; Bos AF
    Neonatology; 2010; 98(3):232-7. PubMed ID: 20389128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy.
    Motti A; Tissot C; Rimensberger PC; Prina-Rousso A; Aggoun Y; Berner M; Beghetti M; da Cruz E
    Pediatr Crit Care Med; 2006 Jul; 7(4):380-2. PubMed ID: 16738499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine infusion for the management of persistent pulmonary hypertension of the newborn.
    Ng C; Franklin O; Vaidya M; Pierce C; Petros A
    Pediatr Crit Care Med; 2004 Jan; 5(1):10-3. PubMed ID: 14697102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of mechanics of breathing in newborns after pharmacological ligation of persistent ductus arteriosus (PDA)].
    Szymankiewicz M; Gadzinowski J
    Przegl Lek; 2002; 59 Suppl 1():25-7. PubMed ID: 12108067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Treatment of Patent Ductus Arteriosus in the Preterm Infant.
    Gregory KE
    J Perinat Neonatal Nurs; 2016; 30(1):6-8. PubMed ID: 26813387
    [No Abstract]   [Full Text] [Related]  

  • 12. [The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
    Distefano G
    Minerva Pediatr; 2005 Feb; 57(1):21-34. PubMed ID: 15791199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itself.
    Oishi P; Fineman JR
    Pediatr Crit Care Med; 2004 Jan; 5(1):94-6. PubMed ID: 14709984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of persistent ductus arteriosus Botalli in the premature infant from the nursing viewpoint].
    Busalt M
    Kinderkrankenschwester; 2008 Sep; 27(9):361-7. PubMed ID: 18841637
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria for use of indomethacin injection in neonates.
    Renfro WH; Burr JM; Rawlings J
    Clin Pharm; 1993 Mar; 12(3):232-4. PubMed ID: 8491081
    [No Abstract]   [Full Text] [Related]  

  • 19. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological closure of patent ductus arteriosus: effects on pulse pressure and on endothelin-1 and vasopressin excretion.
    Zanardo V; Vedovato S; Chiozza L; Faggian D; Favaro F; Trevisanuto D
    Am J Perinatol; 2008 Jun; 25(6):353-8. PubMed ID: 18509786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.